SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Laboratory Corp of America Holdings – ‘10-Q’ for 6/30/19 – ‘EX-31.1’

On:  Thursday, 8/8/19, at 4:13pm ET   ·   For:  6/30/19   ·   Accession #:  920148-19-76   ·   File #:  1-11353

Previous ‘10-Q’:  ‘10-Q’ on 5/3/19 for 3/31/19   ·   Next:  ‘10-Q’ on 10/31/19 for 9/30/19   ·   Latest:  ‘10-Q’ on 4/30/24 for 3/31/24   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 8/08/19  Lab Corp of America Holdings      10-Q        6/30/19   74:11M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.44M 
 2: EX-10.1     Material Contract                                   HTML    109K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     26K 
12: R1          Cover Page                                          HTML     74K 
13: R2          Condensed Consolidated Balance Sheets (Unaudited)   HTML    121K 
14: R3          Condensed Consolidated Balance Sheets (Unaudited)   HTML     23K 
                (Parentheticals)                                                 
15: R4          Condensed Consolidated Statements of Operations     HTML     85K 
                (Unaudited)                                                      
16: R5          Condensed Consolidated Statements of Comprehensive  HTML     59K 
                Earnings (Unaudited)                                             
17: R6          Condensed Consolidated Statements of Changes in     HTML     78K 
                Shareholders' Equity (Unaudited)                                 
18: R7          Condensed Consolidated Statements of Cash Flows     HTML    134K 
                (Unaudited)                                                      
19: R8          Basis of Financial Statement Presentation           HTML     43K 
20: R9          Earnings Per Share                                  HTML     71K 
21: R10         Restructuring and Other Special Charges             HTML     66K 
22: R11         Goodwill and Intangible Assets                      HTML     75K 
23: R12         Debt                                                HTML     78K 
24: R13         Preferred Stock and Common Shareholders' Equity     HTML     88K 
25: R14         Income Taxes                                        HTML     28K 
26: R15         Commitments and Contingencies                       HTML     77K 
27: R16         Pension and Postretirement Plans                    HTML    108K 
28: R17         Fair Value Measurements                             HTML     89K 
29: R18         Derivative Instruments and Hedging Activities       HTML    143K 
30: R19         Supplemental Cash Flow Information                  HTML     55K 
31: R20         Business Acquisitions                               HTML     55K 
32: R21         BUSINESS SEGMENT INFORMATION Business Segment       HTML     71K 
                information (Notes)                                              
33: R22         Leases (Notes)                                      HTML     87K 
34: R23         Earnings Per Share (Tables)                         HTML     73K 
35: R24         RESTRUCTURING AND OTHER SPECIAL CHARGES             HTML     63K 
                Restructuring and Other Special Charges Detail                   
                (Tables)                                                         
36: R25         Goodwill and Intangible Assets (Tables)             HTML     75K 
37: R26         Fair Value Measurements (Tables)                    HTML     86K 
38: R27         Supplemental Cash Flow Information (Tables)         HTML     55K 
39: R28         BUSINESS ACQUISITIONS Business Acquisitions Tables  HTML     31K 
                (Tables)                                                         
40: R29         Business Segment Information (Tables)               HTML     70K 
41: R30         Revenue (Tables)                                    HTML    500K 
42: R31         Leases (Tables)                                     HTML    107K 
43: R32         Basis of Financial Statement Presentation           HTML    123K 
                (Details)                                                        
44: R33         Earnings Per Share (Reconciliation of Basic         HTML     53K 
                Earnings Per Share to Diluted Earnings Per Share)                
                (Details)                                                        
45: R34         Earnings Per Share (Potential common shares not     HTML     24K 
                included in computation of diluted earnings per                  
                share) (Details)                                                 
46: R35         Restructuring and Other Special Charges (Details)   HTML     84K 
47: R36         Restructuring Reserves (Details)                    HTML     60K 
48: R37         Goodwill and Intangible Assets (Changes in          HTML     78K 
                Carrying Amount of Goodwill) (Details)                           
49: R38         Goodwill and Intangible Assets (Components of       HTML     45K 
                identifiable intangible assets) (Details)                        
50: R39         Goodwill and Intangible Assets (Details)            HTML     50K 
51: R40         Debt (Short-term borrowings and current portion of  HTML     50K 
                long-term debt) (Table) (Details)                                
52: R41         Debt (Long-term debt) (Details)                     HTML    110K 
53: R42         Debt (Senior Notes) (Details)                       HTML     79K 
54: R43         Debt (Convertible Subordinated Notes) (Details)     HTML     38K 
55: R44         Debt (Credit Facilities) (Details)                  HTML     98K 
56: R45         Preferred Stock and Common Shareholders' Equity     HTML    103K 
                (Details)                                                        
57: R46         Preferred Stock and Common Shareholders' Equity     HTML     73K 
                PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY -                
                Accumulated Other Comprehensive Earnings (Details)               
58: R47         Income Taxes (Details)                              HTML     29K 
59: R48         Commitments and Contingencies (Details)             HTML     22K 
60: R49         Pension and Postretirement Plans (Details)          HTML    244K 
61: R50         Pension and Postretirement Plans Defined            HTML     36K 
                Contribution Plans (Details)                                     
62: R51         Fair Value Measurements (Details)                   HTML     63K 
63: R52         Derivative Instruments and Hedging Activities       HTML     86K 
                (Details)                                                        
64: R53         Supplemental Cash Flow Information (Details)        HTML     43K 
65: R54         Business Acquisitions (Details)                     HTML    121K 
66: R55         Business Acquisitions Business Acquisitions in the  HTML     40K 
                Aggregate (Details)                                              
67: R56         Business Acquisitions Dispositions (Details)        HTML     67K 
68: R57         BUSINESS SEGMENT INFORMATION Business Segment       HTML     65K 
                Information (Details)                                            
69: R58         REVENUE Disaggregated Revenue Table (Details)       HTML    136K 
70: R59         Leases (Details)                                    HTML    130K 
72: XML         IDEA XML File -- Filing Summary                      XML    133K 
11: XML         XBRL Instance -- lh201910-qq2_htm                    XML   3.23M 
71: EXCEL       IDEA Workbook of Financial Reports                  XLSX     95K 
 7: EX-101.CAL  XBRL Calculations -- lh-20190630_cal                 XML    189K 
 8: EX-101.DEF  XBRL Definitions -- lh-20190630_def                  XML   1.03M 
 9: EX-101.LAB  XBRL Labels -- lh-20190630_lab                       XML   1.91M 
10: EX-101.PRE  XBRL Presentations -- lh-20190630_pre                XML   1.38M 
 6: EX-101.SCH  XBRL Schema -- lh-20190630                           XSD    175K 
73: JSON        XBRL Instance as JSON Data -- MetaLinks              380±   584K 
74: ZIP         XBRL Zipped Folder -- 0000920148-19-000076-xbrl      Zip    342K 


‘EX-31.1’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  


Exhibit 31.1

Certification

I, David P. King, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Laboratory Corporation of America Holdings;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date:
 
 
 
 
By:
 
 
 
 
 
 
Chief Executive Officer
 
 
 
(Principal Executive Officer)




Dates Referenced Herein

This ‘10-Q’ Filing    Date    Other Filings
Filed on:8/8/19None on these Dates
For Period end:6/30/19
 List all Filings 


2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/14/21  Lab Corp. of America Holdings     424B5       5/13/21    1:643K                                   Donnelley … Solutions/FA
 5/12/21  Lab Corp. of America Holdings     424B5                  1:631K                                   Donnelley … Solutions/FA
Top
Filing Submission 0000920148-19-000076   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 7, 7:30:21.1am ET